Reproductive & Genetic Health Solutions for Clinical Labs

I’ve earned my physicians’ trust.
Illumina has earned mine.

Proven solutions at every stage

Our industry leading next-generation sequencing (NGS) and microarray technologies deliver fast, accurate information that can guide choices and transform lives at multiple touchpoints along the reproductive and genetic health care journey.

Existing Customers
If you’re a current customer or visitor from Verinata or BlueGenome, please login here.

Login Now

 

PGS

Preimplantation genetic screening (PGS) has been demonstrated to improve in vitro fertilization (IVF) success rates by selecting the most viable embryos for transfer and implantation.

Learn about PGS

 

PGD

Preimplantation genetic diagnosis (PGD) can be used to screen embryos where there is a risk of severe genetic disorders being inherited from parents.

Learn about PGD

 

NIPT

Noninvasive prenatal testing (NIPT) delivers early, safe, and reliable answers about the chromosomal health of a developing fetus—minimizing the need for riskier invasive procedures.

Learn about NIPT

 

Inherited Condition Screening

Illumina provides a number of other solutions that screen for and detect important genetic conditions and inherited diseases

Learn about Inherited Condition Screening

Cystic Fibrosis Testing Recognizes inherited disease carrier status—providing answers and guidance for prospective parents concerned about passing on genes linked to genetic disorders to their children. Learn about Cystic Fibrosis Testing

Inherited Condition Screening with NGS Detects undiagnosed inherited conditions providing reliable answers and peace of mind for all involved. Learn about Inherited Condition Screening with NGS

Cytogenetics Identifies causes of complex disorders earlier Learn about Cytogenetics

Inherited Cardiac Condition Detects 174 genes related to 17 ICCs Learn about Inherited Cardiac Conditions

Redefining Success

Our advanced genomic solutions are setting new standards of success in reproductive and genetic health, but the data tell only one side of the story. Enhanced patient and provider peace of mind tell the other.


 

Higher Rate of Pregnancy With PGS

In one study, pregnancy rates improved significantly when embryos selected for transfer were screened for normal chromosome numbers compared to conventional morphology methods.1

69.1
With PGS
41.7
Without PGS
10x higher!

10X higher!

The New England Journal of Medicine published study finds verifi Prenatal Test performed by the Illumina clinical lab, achieves 10x higher positive predictive value vs. current standard of care.


Read Study

Cystic Fibrosis Carrier Screening

Cystic Fibrosis Carrier Screening

Highly accurate and reproducible results with ≥ 99.7% overall agreement
for all reported positions and variants for the carrier screening and
diagnostic assays.

 
Choose a section to see more

To learn more about how our innovative genomic solutions can make a life-changing difference in your clinical lab, click on the subjects of interest below.

References

  1. Yang Z, Liu J, Collins GS, Salem SA, Liu X, et al. (2012) Selection of single blastocysts for fresh transfer via standard morphology assessment alone and with array CGH for good prognosis IVF patients: results from a randomized pilot study. Mol Cytogenet 5(1): 24.